Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Exploration of Women's Experiences and Technology Usage Before, During, and After Pregnancy in Singapore

8 de noviembre de 2021 actualizado por: Prof. Dean Ho, National University of Singapore
This study seek to understand the motivations and contextual influences that can induce and sustain behaviour change to inform future interventions for women before, during and after pregnancy, through a qualitative interview-based assessment of 60 participants. As digital health intervention in pregnant women has been shown to be cost-effective and scalable, the current study also aims to understand women's usage of technology throughout the process of trying to conceive, being pregnant and being a new mother within the local Singapore context.

Descripción general del estudio

Estado

Reclutamiento

Descripción detallada

Maternal overweight and obesity is a growing public health concern in Singapore. A recent Singaporean prospective cohort study examined 724 pregnant women and reported that 26.2% of the women had a total gestational weight gain (GWG) which exceed the Institute of Medicine's (IOM) 2009 guidelines. When examined based on body mass index (BMI), overweight and obese women had significantly increased risk of gaining gestational weight above IOM recommendations, compared to normal weight women. Higher GWG have previously been linked to adverse maternal and infant outcomes including higher rates of gestational diabetes mellitus (GDM) and primary caesarean delivery, large for age (LGA) infant, macrosomia and increased risk of childhood overweight/obesity. Given the impact of maternal GWG on pregnancy and infant outcomes, there is a need for a targeted behavioural intervention. As effective health behaviour change requires early initiation and maintenance of change, women before, during and after pregnancy should be targeted. Furthermore, high pre-pregnancy BMI have been shown to be linked with increased risk of GDM and type 2 diabetes post-delivery, and higher infant birthweight, child obesity and atypical child neurodevelopment. Accordingly, this highlights the need for early behavioural intervention beginning with women trying to get pregnant. Current studies have focused predominantly on individual factors contributing to maternal obesity in relation to infant outcomes, both immediately postpartum and prospectively into early childhood. Based on Bronfenbrenner's ecological model, key contextual factors involving the micro-, meso-, exo-, macro- and chronosystem are important factors contributing to the efficacy of digital means on health behavioural change among pregnant women. From this theoretical orientation, understanding individual factors involving motivation and contextual influences is central to facilitating health behaviour change. Specifically, elucidating the proximal (e.g. peers, family) and distal factors (e.g. community, health services) embedded within specific cultural contexts ensure sustainability of behaviour change among pregnant women.

As Singapore is a culturally diverse society, there is a need to understand the impact of cultural factors on maternal behaviours and decision making. Accordingly, the current study will consist of a qualitative assessment of 60 participants who will undergo semi-structured interviews with the aim to understand motivations and contextual influences that induce and sustain behaviour change, so as to inform future interventions for women before, during and after pregnancy. As digital health intervention in pregnant women has been shown to be cost-effective and scalable, the current study also aims to understand women's usage of technology throughout the process of trying to conceive, being pregnant and being a new mother within the local Singapore context.

Tipo de estudio

De observación

Inscripción (Anticipado)

60

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Xavier Tadeo, PhD
  • Número de teléfono: +65 66017766
  • Correo electrónico: lsixtc@nus.edu.sg

Copia de seguridad de contactos de estudio

  • Nombre: Yoong Hun Ong, MSc
  • Número de teléfono: +65 66017766
  • Correo electrónico: yoong@nus.edu.sg

Ubicaciones de estudio

      • Singapore, Singapur, 119074
        • Aún no reclutando
        • National University Hospital
        • Contacto:
        • Contacto:
        • Investigador principal:
          • Shiao-Yng Chan, PhD
        • Sub-Investigador:
          • Yung Seng Lee, PhD
        • Sub-Investigador:
          • Yijuan, Yvonne Lim, MMed
        • Sub-Investigador:
          • Anjian, Andrew Sng, MMed
        • Sub-Investigador:
          • Nicholas Beng Hui Ng, MMed
        • Sub-Investigador:
          • Lin Lin Su, MMed
        • Sub-Investigador:
          • Delicia Shu Qin Ooi, PhD
      • Singapore, Singapur, 117456
        • Reclutamiento
        • The N.1 Institute for Health (N.1), NUS, Singapore
        • Contacto:
        • Contacto:
        • Sub-Investigador:
          • V Vien Lee, PhD
        • Sub-Investigador:
          • Smrithi Vijayakumar, PhD
        • Sub-Investigador:
          • Qiao Ying Leong, BSc
        • Sub-Investigador:
          • Johan Eriksson, Prof
        • Sub-Investigador:
          • Yoann Sapanel, MBA
        • Sub-Investigador:
          • Ni Yin Lau, BSocSci (Hons)
        • Sub-Investigador:
          • Wei Ying Ng, BSocSci (Hons)

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

21 años a 45 años (Adulto)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Femenino

Método de muestreo

Muestra no probabilística

Población de estudio

Women who are actively trying to conceive (pre-pregnancy) or currently in first to third trimester of pregnancy (during pregnancy) or have a child aged 0-2 years (post-pregnancy).

Descripción

Inclusion Criteria:

  • English fluency;
  • Aged 21 years and above;
  • Actively trying to conceive (pre-pregnancy) or currently in first to third trimester of pregnancy (during pregnancy) or have a child aged 0-2 years (post-pregnancy).

Exclusion Criteria:

  • Evidence/diagnosis of cognitive impairment (e.g. history of dementia, intellectual disability, traumatic brain injury);
  • Current diagnosis of psychiatric disorder (e.g. severe anxiety, depression, schizophrenia);
  • Significant hearing impairment;
  • Inability to complete the study at the judgement of the clinician investigators;
  • Women requiring or who had any form of assisted conception.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Pre-pregnancy
During pregnancy
Post-pregnancy

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Experiences and technology usage among women
Periodo de tiempo: 1 year
We will conduct semi-structured interviews with women who are either trying to conceive, pregnant or have a child aged 0 to 2 years. The interviews seek to find out about the participants' pregnancy/maternal-related experiences including the challenges faced, lifestyle changes made, support systems and experience with the health system. Participants will also be asked about their previous and current experiences with technology usage, such as the type of technology used and the purposes of technology usage. Additionally, there will also be two questionnaires, conducted pre- and post-interview, on the participants' demographics and their opinions on technical aspects of digital platforms.
1 year

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Dean Ho, Prof, National University of Singapore

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

8 de noviembre de 2021

Finalización primaria (Anticipado)

8 de mayo de 2022

Finalización del estudio (Anticipado)

8 de noviembre de 2022

Fechas de registro del estudio

Enviado por primera vez

15 de septiembre de 2021

Primero enviado que cumplió con los criterios de control de calidad

28 de octubre de 2021

Publicado por primera vez (Actual)

29 de octubre de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

10 de noviembre de 2021

Última actualización enviada que cumplió con los criterios de control de calidad

8 de noviembre de 2021

Última verificación

1 de noviembre de 2021

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir